News about

Syntegon's SBM Introduces New Sterilizer Series for Pharmaceutical Manufacturers

Syntegon's SBM Introduces New Sterilizer Series for Pharmaceutical Manufacturers

Christian Dallner, SBM's product manager, highlights the standardized basis of the SBM Essential Line, which promises shorter delivery times and competitive prices for pharmaceutical manufacturers.

| 12/03/2024 | By 1048

Gennova BioPharma Announces the Launch of HAMSYL Junior

Gennova BioPharma Announces the Launch of HAMSYL Junior

Gennova Biopharmaceuticals Ltd., announces the launch of the India’s first paediatric pack size of pegaspargase – HAMSYL – Junior, which will now be available in a 1500 IU pack size.

| 11/03/2024 | By 1228

NRx Pharmaceuticals Completes MoU and Collaborations with Distribution Partners for HTX-100 (IV Ketamine)

NRx Pharmaceuticals Completes MoU and Collaborations with Distribution Partners for HTX-100 (IV Ketamine)

These are important steps to providing a full suite of ketamine options for customers across the country, and preparation for potential approval of HTX-100 by regulatory authorities worldwide.

| 11/03/2024 | By 367

FDA Approves Wegovy for Cardiovascular Risk Reduction in Adults with Obesity

FDA Approves Wegovy for Cardiovascular Risk Reduction in Adults with Obesity

Obesity and overweight afflict approximately 70 percent of American adults, posing grave health hazards that elevate the likelihood of premature mortality and a spectrum of health ailments, including heart attack and stroke.

| 11/03/2024 | By 1195

PulseCath Achieves MDR CE Certification for iVAC 2L System

PulseCath Achieves MDR CE Certification for iVAC 2L System

This certification signifies PulseCath's unwavering dedication to upholding the highest standards of quality and safety in medical device technology.

| 11/03/2024 | By 442

Vanda Pharmaceuticals Receives Complete Response Letter from FDA for Insomnia Treatment

Vanda Pharmaceuticals Receives Complete Response Letter from FDA for Insomnia Treatment

The issuance of the CRL signifies that the FDA cannot approve the sNDA in its current form, as confirmed by Vanda.

| 07/03/2024 | By 572

Epsilogen and Lonza Achieve Breakthrough in Cancer Treatment with MOv18 IgE Antibody

Epsilogen and Lonza Achieve Breakthrough in Cancer Treatment with MOv18 IgE Antibody

The companies have successfully completed the Good Manufacturing Practice (GMP) manufacturing of MOv18 IgE, Epsilogen’s leading IgE antibody drug candidate.

| 07/03/2024 | By 727

Velsera Announces Appointment of Jamie Littlejohns as New Chief Executive Officer

Velsera Announces Appointment of Jamie Littlejohns as New Chief Executive Officer

Jamie is set to succeed Hans Cobben, who has served as the interim CEO and will revert to his position as Chairman of the Board at Velsera.

| 06/03/2024 | By 309

CleanNA Launches CE-IVD Product for Quick and Reliable Viral DNA and RNA Extraction

CleanNA Launches CE-IVD Product for Quick and Reliable Viral DNA and RNA Extraction

The company’s Clean Quick Viral DNA/RNA (CE-IVD) extracts viral DNA and RNA from nasopharyngeal or oropharyngeal swab samples preserved in an inactivating viral transport medium.

| 06/03/2024 | By 519

Clear Guide Medical Receives FDA Clearance for SCENERGY System

Clear Guide Medical Receives FDA Clearance for SCENERGY System

The CLEAR GUIDE SCENERGY system represents a leap forward in image-guided diagnostic and interventional procedures, offering unparalleled accuracy and precision.

| 06/03/2024 | By 484

 
 

 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members